MedPath

The Effects of Insomnia Treatment on Overnight Regulation of Emotional Memories and Risk for Mental Disorders

Not Applicable
Not yet recruiting
Conditions
Insomnia Chronic
Depression, Anxiety
Registration Number
NCT06567210
Lead Sponsor
Woolcock Institute of Medical Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> - Diagnosis of insomnia disorder (DSM-V-TR) or ISI score = 10.<br><br> - All sexes and genders.<br><br> - Between 25 and 45 years of age.<br><br> - Able to provide informed consent.<br><br> - Proficient in English.<br><br>Exclusion Criteria:<br><br> - Sleep or circadian disorder other than insomnia (e.g., hypersomnolence, periodic<br> limb movement disorder, advanced or delayed sleep phase disorder, moderate to severe<br> sleep apnoea disorder based on previous sleep study with an apnea-hypopnea index =<br> 15 and/or STOP-BANG high-risk score and/or finger-pulse oximetry oxygen desaturation<br> index (ODI) = 10).<br><br> - Any contradictions for MRI (e.g., claustrophobia, presence of metal in body,<br> cochlear implants).<br><br> - Current or history of neurological disorders (e.g., stroke, brain injury).<br><br> - Current or history of any disorder listed in DSM-V other than major depression and<br> anxiety disorders (post-traumatic stress disorder is excluded).<br><br> - Centrally active agents or presence of medical condition that may affect<br> participation.<br><br> - Pregnancy or actively trying to conceive, or lactating.<br><br> - Shift work for at least 2 shifts per week in the past 3 months (i.e., work between<br> 21:00 and 6:00).<br><br> - Travel across time zones over 3 hours difference in the previous 30 days (will<br> require a 1-week adjustment period per hour of time zone travelled).<br><br> - Unwilling to know about potential incidental findings.<br><br> - No consent or adherence to instructions for any part of the study protocol.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insomnia Severity Index (ISI) score;Patient Health Questionnaire-9 (PHQ-9) score;General Anxiety Disorder-7 (GAD-7) score
Secondary Outcome Measures
NameTimeMethod
EEG sleep efficiency (SE - %);EEG total sleep time (TST - minutes);EEG wake duration (minutes);EEG sleep onset latency (SOL - minutes);EEG sleep stages (%);Actigraphy sleep efficiency (%);Actigraphy total sleep duration (minutes);Actigraphy wake duration (minutes);Actigraphy sleep onset latency (minutes);7-days light exposure (lux);Hour of Dim-Light Melatonin Onset (HDLMO - hour);3-days distal-proximal skin-temperature gradients (DPG);Self-reported sleep duration (min);Self-reported wake duration (min);Self-reported sleep onset latency (min);Self-reported sleep quality (out of 5);Sleep misperception index (SPI - %)
© Copyright 2025. All Rights Reserved by MedPath